**Participation in the National R&D Project for "Implantable Medical Devices"**  

MiST(KOREA) CO., LTD. (MST, Chairman: Woong-Sik Moon, [www.BioCleanAct.com](http://www.BioCleanAct.com), Brand: BioCleanAct™) Central Research Institute was selected for the **Regional Specialized Industry Promotion + (R&D) Regional Star Enterprise Promotion Project** and has been conducting a **national research and development project for two years (2023–2024).**  

**[Development of a high-pressure 5Fr, 325psi peripherally inserted central catheter (PICC) for the prevention of bloodstream infections using a natural compound-based TPU antibacterial compound]**  

MST successfully carried out and completed a **national R&D commercialization project** for an **Infection-free implantable PICC** incorporating its **natural compound-based antibacterial material.**  

Furthermore, MST's **new natural antibacterial material** (for secondary bacterial infection prevention) has been the subject of joint research and development in the medical device sector with:  

- Kuraray Group Medical Division (Japan)  

- Siemens Healthineers (Germany)  

- Samsung Electronics Medical Division  

- Sewoon Medical, and others.